Stay updated on MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial
Sign up to get notified when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.

Latest updates to the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now indicates enrollment is closed and new help/navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study). In addition, the Intervention/Treatment heading formatting was adjusted, and the revision version updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check18 days agoChange DetectedA new revision tag v3.5.5 has been introduced, replacing the previous v3.5.4, indicating an update to the page's revision metadata.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page's version label in the footer was updated from Revision: v3.5.3 to Revision: v3.5.4. This reflects a minor site maintenance update and does not change any study information or functionality.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page footer revision label was updated from **v3.5.0** to **v3.5.3**, indicating a site/version update rather than a change to the underlying study information.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.1%

- Check112 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.